Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Share-based Compensation (2022 - 2025)

Historic Share-based Compensation for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $36.0 million.

  • GE HealthCare Technologies' Share-based Compensation rose 909.09% to $36.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $130.0 million, marking a year-over-year increase of 400.0%. This contributed to the annual value of $130.0 million for FY2025, which is 400.0% up from last year.
  • According to the latest figures from Q4 2025, GE HealthCare Technologies' Share-based Compensation is $36.0 million, which was up 909.09% from $38.0 million recorded in Q3 2025.
  • In the past 5 years, GE HealthCare Technologies' Share-based Compensation registered a high of $38.0 million during Q3 2025, and its lowest value of $9.0 million during Q4 2022.
  • Moreover, its 4-year median value for Share-based Compensation was $28.5 million (2023), whereas its average is $27.2 million.
  • Its Share-based Compensation has fluctuated over the past 5 years, first surged by 26666.67% in 2023, then plummeted by 3529.41% in 2025.
  • Quarter analysis of 4 years shows GE HealthCare Technologies' Share-based Compensation stood at $9.0 million in 2022, then skyrocketed by 266.67% to $33.0 million in 2023, then changed by 0.0% to $33.0 million in 2024, then rose by 9.09% to $36.0 million in 2025.
  • Its Share-based Compensation stands at $36.0 million for Q4 2025, versus $38.0 million for Q3 2025 and $34.0 million for Q2 2025.